Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Granulocyte Colony-Stimulating Factor × 90 days × Clear all

Phase

Phase 2 18 Phase 1 10 Phase 3 6 Phase 1/2 5 Phase NA 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 4 Prednisone 4 Dexamethasone 4 enzalutamide 3 darolutamide 3 Tobacco Use Cessation Devices 3 Rituximab 3 Magnetic Resonance Spectroscopy 3 Injections 3 Hydromorphone 3 Cisplatin 3 Carboplatin 3 zanubrutinib 2 trametinib 2 ribociclib 2 pirtobrutinib 2 pembrolizumab 2 obinutuzumab 2 gadolinium ethoxybenzyl DTPA 2 enfortumab vedotin 2 dabrafenib 2 Watchful Waiting 2 Vincristine 2 Standard of Care 2 Propofol 2 Paclitaxel 2 Oxaliplatin 2 Observation 2 Methotrexate 2 Leuprolide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05753618 2026-02-09

REaCT-OGF

Ottawa Hospital Research Institute

Phase 4 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡